Late stage antibacterial drugs in the clinical pipeline

This publication has 24 references indexed in Scilit:

• Antimicrobial Resistance Prevention Initiative—An Update: Proceedings of an Expert Panel on Resistance
  The American Journal of Medicine, 2007
• (Genome) Size Matters
  Antimicrobial Agents and Chemotherapy, 2007
• Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
  Clinical Infectious Diseases, 2006
• A Clone of Methicillin-ResistantStaphylococcus aureusamong Professional Football Players
  New England Journal of Medicine, 2005
• Trends in Antimicrobial Drug Development: Implications for the Future
  Clinical Infectious Diseases, 2004
• Antibacterial drug discovery: is it all downhill from here?
  Clinical Microbiology & Infection, 2004
• Do we really need new anti-infective drugs?
  Current Opinion in Pharmacology, 2003
• Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen
  Infection Control & Hospital Epidemiology, 2003
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center
  Clinical Infectious Diseases, 1996